Skip to main content
Fig. 3 | Orphanet Journal of Rare Diseases

Fig. 3

From: Evaluation of NACA and diNACA in human cystinosis fibroblast cell cultures as potential treatments for cystinosis

Fig. 3

HCFs viability (expressed as percentage of treatment-free control) following incubation with 25, 50 or 75 µM cysteamine, NPI-001 (NACA) or NPI-002 (diNACA) at 48 and 72 h. Data shown are the mean of 5 independent measurements, ± S.E.M. Level of significance at 48 and 72 h was determined by paired t-test versus the respective treatment-free control (*p < 0.05, **p < 0.005) or respective cysteamine treated sample (#p < 0.05)

Back to article page